Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Krystal Biotech, Inc. (KRYS) had Return on Investments of 3.63% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$88.18M |
|
$35.73M |
|
$5.03M |
|
$83.16M |
|
$52.01M |
|
$36.18M |
|
$7.42M |
|
$43.60M |
|
$43.60M |
|
$35.73M |
|
$35.73M |
|
$35.73M |
|
$35.73M |
|
$36.18M |
|
$37.81M |
|
28.82M |
|
29.87M |
|
$1.24 |
|
$1.20 |
|
| Balance Sheet Financials | |
$766.80M |
|
$151.07M |
|
$307.62M |
|
$1.07B |
|
$79.49M |
|
-- |
|
$10.25M |
|
$89.74M |
|
$984.67M |
|
$984.67M |
|
$984.67M |
|
28.90M |
|
| Cash Flow Statement Financials | |
$30.97M |
|
$-54.77M |
|
$-12.47M |
|
$344.87M |
|
$308.77M |
|
$-36.09M |
|
$13.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
94.30% |
|
41.02% |
|
41.02% |
|
-- |
|
49.44% |
|
40.52% |
|
$25.20M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.17 |
|
0.85 |
|
105.39 |
|
3.63% |
|
3.63% |
|
3.33% |
|
|
Return on Investments |
3.63% |
$34.07 |
|
$0.84 |
|
$1.04 |
|